Efficacy, suicidality, tolerability, and acceptability of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors for children and adolescents with anxiety disorders: a systematic review and meta-analysis [0.03%]
选择性五羟色胺再摄取抑制剂和五羟色胺-去甲肾上腺素再摄取抑制剂治疗儿童及青少年焦虑障碍的有效性、自杀风险、耐受性和接受度：系统评价和网络 Meta 分析
Nuntaporn Karawekpanyawong,Chawanun Charnsin,Sirijit Suttajit et al.
Nuntaporn Karawekpanyawong et al.
This systematic review and meta-analysis included randomized controlled trials (RCTs) to compare the efficacy, (treatment-emergent) suicidality, tolerability, and acceptability of selective serotonin reuptake inhibitors (SSRIs) and serotoni...
Long-term safety and tolerability of lumateperone 42 mg in patients with bipolar disorder: results from a 6-month open-label extension study [0.03%]
卢马西泮治疗双相障碍患者长期安全性和耐受性：一项为期6个月开放标签延伸研究结果
Mauricio Tohen,Suresh Durgam,Susan G Kozauer et al.
Mauricio Tohen et al.
This 6-month open-label extension (OLE) period of a Phase 3 placebo-controlled study (NCT02600494) examined the safety of lumateperone in patients with bipolar I or bipolar II depression. Eligible patients completing the placebo-controlled ...
Glucagon-like peptide-1 receptor agonist semaglutide through the lens of psychiatry: a systematic review of potential benefits and risks [0.03%]
从精神病学角度看利拉鲁肽类似物塞马鲁肽的潜在益处和风险：系统综述
Matteo Carminati,Mattia Tondello,Arianna Concina et al.
Matteo Carminati et al.
Semaglutide (SEM), a long-acting glucagon-like peptide-1 receptor agonist, affects neural circuits regulating food intake and satiety, and it provides neuroprotective effects; however, SEM may influence psychological functioning, possibly l...
Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition [0.03%]
提高成人ADHD诊断意识：应对诊断挑战、共病及正确认识的道路
Camilla Elefante,Giulio Perugi
Camilla Elefante
Innovations and challenges in antipsychotic treatments and external modulating factors [0.03%]
抗精神病药物治疗的创新与挑战及外调因素的影响问题
Alessandro Serretti
Alessandro Serretti
Agostina Secchi,Madelaine Bridges,Eromona Whiskey et al.
Agostina Secchi et al.
Neutropenia and the more severe, potentially life-threatening agranulocytosis are recognized side effects of clozapine that require regular, mandatory, and life-long blood monitoring. However, most cases of haematological adverse effects oc...
Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial [0.03%]
利培酮联合治疗双相障碍患者的强迫症状：随机双盲安慰剂对照临床试验
Ali Sahraian,Mahsa Ghavipisheh,Leila Razeghian Jahromi et al.
Ali Sahraian et al.
Treatment of obsessive-compulsive disorder (OCD) symptoms in patients with bipolar disorder (BD) is challenging. In this research, the therapeutic effects of risperidone on OCD symptoms in patients with BD are investigated. Forty-two patien...
Efficacy and safety of adjunctive therapy with lumateperone in major depressive disorder: a randomized-, double-blind, placebo-controlled clinical trial [0.03%]
卢马特派rone作为辅助治疗重度抑郁症的疗效和安全性：随机、双盲、安慰剂对照临床试验
Zahra Hosseinnia,Mobina Amanollahi,Bahareh Ahli et al.
Zahra Hosseinnia et al.
This study aimed to investigate the effects of lumateperone as a combination therapy with sertraline in major depressive disorder (MDD). The 8-week, double-blind, placebo-controlled trial was registered with the Iranian Registry of Clinical...
Effects of transcranial direct current stimulation (tDCS) at different cortical targets on cognition in obsessive-compulsive disorder (OCD): an exploratory analysis [0.03%]
针对强迫症(tDCS)不同皮层靶点的经颅直流电刺激(tDCS)对认知的影响：一项探索性分析
Luca Pellegrini,Eduardo Cinosi,David Wellsted et al.
Luca Pellegrini et al.
Transcranial direct current stimulation (tDCS) holds promise as a treatment for obsessive-compulsive disorder (OCD). Patients with OCD show impairment in specific domains of cognitive flexibility and response inhibition. We previously repor...
Alessandro Serretti
Alessandro Serretti